How will the biostatistics industry evolve in the coming years? Is SAS still an important skill recruiters look at when hiring for a biostatistics related job?

In this episode, you will hear Doctor Xiaoling Wu answering these questions after being in the field for over 15 years. Xiaoling holds a PhD degree in statistics from the Johns Hopkins University. She has contributed to over 10 successful global submission of drugs treating cancer and CNS disorder. She was the director and head of biostatistics in Legend Biotech in New Jersey. And led the successful BLA submission of a breakthrough cell therapy treating multiple myeloma during her 3 year tenure. Currently, Xiaoling is the statistics technical lead of a game changing ADC at a leading global oncology company.

Xiaoling was lead statistician of five successful IND clearance and 1 BLA/MAA/PMDA approval valued at $5B. She addressed statistics query from FDA, SEC and institution investors and co-authored over 150 abstracts published at ASCO, ASH and other international medical congress. Let's dive in this episode to see what Xiaoling shared with us

Please visit our website https://biostatisticspodcast.github.io/ for the latest updates and transcripts of the published episodes.
If you have any comments, feedback or suggestions, feel free to email us via biostatisticspodcast@gmail.com or DM us on Twitter @BiostatsPodcast